OpenSAFELY Vaccine Coverage Report

AstraZeneca / Priority Group 1

Data from combined, up to 2021-03-07.

Vaccinated at 2021-03-07 (%) Vaccinated at 2021-03-07 (n) Population Vaccinated at 2021-02-28 (%) Vaccinated in past week (%)
Overall - 65.0% 195,622 300,916 63.7% 1.3%
Sex Female 65.7% 125,636 191,233 64.7% 1.0%
Male 63.8% 69,986 109,683 61.8% 2.0%
Ethnicity White - British 65.5% 125,223 191,044 64.2% 1.4%
White - Irish 66.9% 1,673 2,499 66.4% 0.6%
White - Any other White background 56.1% 3,521 6,272 54.7% 1.5%
Mixed - White and Black Caribbean 55.8% 336 602 52.3% 3.5%
Mixed - White and Black African 47.2% 119 252 47.2% 0.0%
Mixed - White and Asian 60.6% 140 231 54.5% 6.1%
Mixed - Any other mixed background 57.4% 273 476 52.9% 4.4%
Asian or Asian British - Indian 61.2% 1,260 2,058 59.5% 1.7%
Asian or Asian British - Pakistani 51.2% 448 875 48.8% 2.4%
Asian or Asian British - Bangladeshi 55.9% 231 413 50.8% 5.1%
Asian or Asian British - Any other Asian background 56.5% 672 1,190 54.1% 2.4%
Black or Black British - Caribbean 55.4% 1,260 2,275 54.2% 1.2%
Black or Black British - African 46.3% 651 1,407 43.8% 2.5%
Black or Black British - Any other Black background 54.7% 406 742 50.9% 3.8%
Other ethnic groups - Chinese 58.0% 203 350 54.0% 4.0%
Other ethnic groups - Any other ethnic group 56.3% 658 1,169 51.5% 4.8%
Patients with any other ethnicity code 66.6% 25,865 38,822 65.2% 1.4%
Ethnicity not stated 63.9% 1,757 2,751 63.1% 0.8%
Ethnicity not recorded 65.1% 30,828 47,362 64.2% 0.9%
Ethnicity (broad categories) White 65.3% 130,424 199,829 63.9% 1.4%
Mixed 55.8% 882 1,582 51.8% 4.0%
South Asian 57.8% 2,639 4,564 55.4% 2.5%
Black 52.5% 2,331 4,438 50.5% 2.1%
Other 56.7% 861 1,519 52.5% 4.1%
Unknown 65.7% 58,457 88,949 64.6% 1.1%
Index of Multiple Deprivation 1 (most deprived) 62.5% 66,878 107,002 61.2% 1.3%
2 67.0% 34,041 50,799 65.5% 1.6%
3 67.7% 34,594 51,121 66.4% 1.3%
4 65.7% 32,165 48,986 64.4% 1.3%
5 (least deprived) 65.3% 26,859 41,153 64.1% 1.1%
Unknown 58.0% 1,064 1,834 55.3% 2.7%
Clinical Risk Groups Patients in Any Clinical Risk Group 66.1% 171,325 259,273 64.7% 1.4%
Patients with Immunosuppression 64.4% 5,894 9,149 63.1% 1.3%
Patients with CKD 65.7% 49,175 74,823 65.1% 0.6%
Patients who have Chronic Respiratory Disease 65.0% 18,109 27,881 64.0% 0.9%
Patients with Diabetes 65.5% 37,205 56,812 64.4% 1.1%
Patients with Chronic Liver disease 63.7% 4,991 7,840 61.8% 1.9%
Patients with CNS Disease (including Stroke/TIA) 67.4% 102,606 152,292 66.1% 1.2%
Patients with Chronic heart disease 65.8% 71,176 108,185 65.1% 0.7%
Patients with Asplenia or Dysfunction of the Spleen 66.0% 1,505 2,282 64.7% 1.2%
Patients with Wider Learning Disability 71.2% 32,032 44,968 67.0% 4.2%
Patients with Severe Mental Health 63.5% 19,061 30,002 61.3% 2.2%
Other Groups Patients who are shielding (High Risk from COVID-19) 66.9% 141,582 211,554 66.2% 0.7%
Patients with Morbid Obesity 63.8% 5,201 8,148 60.8% 3.0%
Patients who are pregnant 21.1% 28 133 15.8% 5.3%